维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Ching AK"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	miR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling显示文摘	Wong QW Ching AK Chan AW	2010	Clin Cancer Res2010，16，3：	1
2	Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers:a placebo-controlled trial显示文摘	Lai CL Ching CK Tung AK	1997	Hepatology1997，25，：	1
3	miR-124 is frequently down- regulated in medulloblastoma and is a negative regulator of SLC 16A1 显示文摘	Li KK Pang JC Ching AK	2009	Hum Pathol2009，40，9：	1
4	Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma显示文摘	Law PT Qin H Ching AK		0，，6：	1
5	BRE over-expression promotes growth of hepatocellular carcinoma 显示文摘	Chui YL Ching AK Chen S	2010	Biochem Biophys Res Commun2010，391，：	1
6	MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling 显示文摘	Wong QW Ching AK Chan AW	2010	Clin Cancer Res2010，16，3：	1
7	Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial- to-mesenchymal transition显示文摘	Chung KY Cheng IK Ching AK	2011	Hepatology2011，54，1：	1
8	Function significance of coronary collateral vessels in pa- tients with previous 'Q' wave infarction: relation to an- eurysm, left ventricular end diastolic pressure and ejec- tion fraction显示文摘	Baneijee AK Madan-Mohan SK Ching GW	1993	Int J Cardiol1993，38，3：	1
9	MiR - 222 overexpressiorl confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling 显示文摘	Wong Qw Ching AK Chan AW	2010	Clin Cancer Res2010，16，3：	1
10	Functional significance of coronary collateral vessels in patients with previous ‘Q' wave infarction relation to aneurysm,left ventricular end diastolic pressure and ejection fraction显示文摘	Madan-Mohan SK Ching GW	1993	Int J Cardiol1993，38，：	1
11	Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controUed trial 显示文摘	Lai CL Ching CK Tung AK	1997	Hepatology1997，25，1：	1
12	miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1 显示文摘	Li KK Pang JC Ching AK	2009	Hum Pathol2009，40，9：	1
13	Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition显示文摘	Chung KY Cheng IK Ching AK	2011	Hepatology2011，54，1：	1
14	MiR-222 overex- pression confers cell migratory advantages in hepatocellu- lar carcinoma through enhancing AKT signaling 显示文摘	Wong QW Ching AK Chan AW	2010	Clin Cancer Res2010，16，3：	1
15	MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling显示文摘	Wong QW Ching AK Chan AW	2010	Clin Cancer Res2010，16，3：	1
16	Mir-222 overexpres- sion confers cell migratory advantages in hepatocellular carcino- ma through enhancing AKT signaling 显示文摘	Wong QW Ching AK Chan AW	2010	Clin Cancer Res2010，16，3：	1
17	Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo -controlled trial显示文摘	Lai CL Ching CK Tung AK	1997	Hepatology1997，25，1：	1
18	miR-124 is frequently down-regulated in medulloblasto and is a negative regula?tor of SLCI6AI显示文摘	Li KK PangJC Ching AK	2009	Hum Pathol2009，40，9：	1
19	MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling显示文摘	Wong QW Ching AK Chan AW	2010	Clin Cancer Res2010，16，3：	1
20	MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma显示文摘	Law PT Ching AK Chan AW	2012	Carcinogenesis2012，33，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示